Brown Capital Management’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
Other funds holding TXG
AIM
NAMA
Brown Capital Management's TXG Position: Q1 2025 in Review
Brown Capital Management sold out of 10x Genomics (TXG) in Q1 2025, closing a stake of 1,843,960 shares — an estimated $26.5M sold.
Brown Capital Management first reported a position in TXG in Q4 2020 and held it in 17 quarters. The position peaked at $241M in Q2 2021. 274 funds tracked by Wall St. Rank hold TXG as of Q1 2025.
- Brown Capital Management reported no remaining 10x Genomics position as of Q1 2025 after selling out during the quarter.
- Brown Capital Management sold 1,843,960 10x Genomics shares in Q1 2025, an estimated $26.5M.
- Brown Capital Management first reported a position in 10x Genomics in Q4 2020 and held it in 17 quarters.
- Brown Capital Management's 10x Genomics position peaked at $241M in Q2 2021.
- 274 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2025.
Based on Brown Capital Management's 13F filing for Q1 2025, filed 15 May 2025.